Urology · Benign Prostatic Hyperplasia

Surgical and Minimally Invasive Treatments

At a Glance

Choosing a BPH procedure means balancing urinary relief and durability against recovery time and sexual effects. TURP and HoLEP usually improve flow more durably, while UroLift and Rezūm may recover faster and better preserve ejaculation but can have more modest results or require retreatment.

When medications are no longer effective or if your enlarged prostate begins to cause physical damage to your urinary system, surgical intervention may be necessary. Modern urology offers a spectrum of choices, from traditional “gold standard” surgeries to newer, minimally invasive therapies that prioritize a quick recovery and the preservation of sexual function ^[1]^[2].

When Surgery Becomes Necessary

While many men choose surgery because their symptoms are simply too bothersome, there are several common reasons to consider moving beyond medication:

Refractory Retention: Being unable to urinate even while on medication or after multiple failed attempts to remove a catheter ^[3]^[1].
Physical Damage: The presence of bladder stones, recurrent urinary tract infections (UTIs), or persistent blood in the urine attributable to BPH ^[3]^[4].
Kidney Strain: Signs that the backup of urine is causing pressure on the kidneys (hydronephrosis) or decreasing kidney function ^[5]^[6].

Traditional Surgical Options

These procedures involve removing or destroying the prostate tissue that is blocking the urethra. They typically offer the most significant and long-lasting improvement in urine flow.

TURP (Transurethral Resection of the Prostate): Long considered the gold standard, a surgeon uses an electrified wire loop to “whittle away” the obstructing tissue. It is highly effective but is generally best suited for moderate-sized prostates (roughly 30 to 80 mL) ^[7]^[8].
HoLEP (Holmium Laser Enucleation of the Prostate): This is a “size-independent” procedure, meaning it can be used for very large prostates (over 80 mL) that would otherwise require open surgery ^[9]^[7]. The surgeon uses a laser to peel away the entire obstructing portion of the prostate. HoLEP generally results in less bleeding, shorter hospital stays, and a lower risk of the tissue growing back compared to TURP ^[8]^[10].

Minimally Invasive Surgical Therapies (MISTs)

If you wish to avoid the side effects or recovery time of major surgery, MISTs are performed as outpatient procedures. They are typically used for moderate-sized prostates (30–80 mL) ^[11]^[12].

UroLift (Prostatic Urethral Lift): Small permanent implants are placed to “curtain back” the prostate tissue, widening the urethra without removing any tissue ^[12]^[13].
Rezūm (Water Vapor Thermal Therapy): This procedure uses injections of steam to kill the obstructing prostate cells, which the body then naturally absorbs over several weeks ^[11]^[14]. Note that Rezūm commonly has delayed symptom improvement over weeks to months, and patients may require a catheter initially.

The Trade-Offs: Recovery vs. Durability

Choosing between a MIST and a major surgery involves balancing your priorities:

Feature	MIST (Rezūm/UroLift)	Major Surgery (TURP/HoLEP)
Recovery	Very fast; often outpatient ^[15]	Varies: 1–2 days hospital stay; weeks of healing ^[16]
Sexual Function	High chance of preserving ejaculation ^[17]	High risk (often >75% for HoLEP) of retrograde ejaculation ^[18]
Flow Improvement	Moderate improvement ^[19]	Significant, long-lasting improvement ^[8]
Retreatment Risk	Higher (ranges vary from 3.4% to 21% depending on device/study) ^[20]	Very low (approx. 3–7% over 5 years, varying by procedure) ^[10]

Understanding Side Effects

Every prostate procedure carries some risk. Retrograde ejaculation—where semen travels into the bladder during climax rather than out of the penis—is very common after TURP and HoLEP but is not harmful to your health ^[18]^[8]. It is important to distinguish this from erectile dysfunction, as erections and orgasm are typically preserved. Since permanent loss of normal ejaculation can affect fertility, discuss sperm preservation before a procedure if this matters to you. Recovery also involves managing expectations: the first days and weeks may involve expected catheter use, temporary burning, urgency, or blood in the urine. Seek urgent care for fever, heavy bleeding, or inability to pass urine. Finally, acknowledge that additional options like Aquablation, simple prostatectomy, or prostatic artery embolization may be appropriate for selected prostate sizes and anatomies. Other risks include urethral strictures (internal scarring that can narrow the urinary path) or temporary “leaking” (incontinence) while the bladder heals ^[21]^[16]. Your doctor will use your prostate size and personal health goals to help you choose the path that best fits your life.

Common questions in this guide

When should I consider a procedure for an enlarged prostate?

A procedure may be considered when medicines do not control bothersome symptoms or when complications develop. Common reasons include repeated inability to urinate, bladder stones, recurrent urinary tract infections, persistent blood in the urine, or urine backup that strains the kidneys. A urologist can assess whether continuing medication is safe for you.

How do TURP and HoLEP differ for BPH?

TURP removes blocking prostate tissue with an electrified wire loop and is generally used for prostates measuring about 30 to 80 mL. HoLEP uses a laser to peel out the obstructing portion and can be used for very large prostates. HoLEP generally causes less bleeding, shorter hospital stays, and less tissue regrowth than TURP, although results depend on the individual and the surgeon.

Are UroLift and Rezūm alternatives to major prostate surgery?

UroLift and Rezūm are minimally invasive procedures often used for moderately enlarged prostates. UroLift holds prostate tissue away from the urethra, while Rezūm uses steam to destroy tissue that the body absorbs over time. They may offer faster recovery and better preservation of ejaculation than TURP or HoLEP, but urine-flow improvement may be more modest and repeat treatment may be more likely.

Will BPH treatment change ejaculation or erections?

TURP and HoLEP commonly cause retrograde ejaculation, meaning semen enters the bladder instead of leaving through the penis; this is usually not harmful, and erections and orgasm are typically preserved. UroLift and Rezūm have a higher chance of preserving normal ejaculation, but no procedure is risk-free. If fertility matters to you, discuss sperm preservation before treatment.

What should I expect during recovery after BPH treatment?

Recovery varies by procedure and may include temporary catheter use, burning with urination, urgency, or blood in the urine. After Rezūm, symptom improvement is often delayed for weeks to months, and a catheter may be needed at first. Seek urgent care for fever, heavy bleeding, or inability to pass urine.

Curated prompts to bring to your next appointment.

1.Based on my prostate volume and whether I have a median lobe, which procedures are technically feasible and typically recommended for my anatomy?
2.If I choose a minimally invasive option like Rezūm, what should I expect regarding temporary worsening of symptoms or needing a catheter?
3.What is your personal experience and volume with HoLEP, and how do your patients' rates of complications compare to average?
4.If preserving normal ejaculation is my top priority, which procedure offers the best balance of symptom relief and sexual preservation?
5.Do I have any common indications for surgery, such as signs of kidney strain or recurrent bladder stones, that make continuing medication less safe?

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

Key takeaways

Surgery may be needed when BPH medicines fail or when urinary retention, bladder stones, recurrent infections, blood in the urine, or kidney strain develops.
TURP is generally used for moderate-sized prostates, while HoLEP can treat very large prostates and often offers less bleeding, shorter stays, and durable relief.
UroLift and Rezūm are less invasive options that may support faster recovery and ejaculation preservation but can provide more modest flow improvement and carry a higher retreatment risk.
Retrograde ejaculation is common after TURP and HoLEP but is usually not harmful, and erections and orgasm are typically preserved.
Temporary catheter use, burning, urgency, or blood in the urine can occur during recovery; fever, heavy bleeding, or inability to urinate requires urgent medical attention.

References (21)

1
Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART II-Surgical Evaluation and Treatment.
Lerner LB, McVary KT, Barry MJ, et al.
The Journal of urology 2021; (206(4)):818-826 doi:10.1097/JU.0000000000002184.
PMID: 34384236
2
Summary Paper on the 2026 European Association of Urology Guidelines on the Management of Non-neurogenic Male Lower Urinary Tract Symptoms.
Baboudjian M, Creta M, Pyrgidis N, et al.
European urology 2026; (90(1)):44-59 doi:10.1016/j.eururo.2026.03.020.
PMID: 41997777
3
Management of Benign Prostatic Hyperplasia.
Kim EH, Larson JA, Andriole GL
Annual review of medicine 2016; (67()):137-51 doi:10.1146/annurev-med-063014-123902.
PMID: 26331999
4
Medical and Surgical Treatment Modalities for Lower Urinary Tract Symptoms in the Male Patient Secondary to Benign Prostatic Hyperplasia: A Review.
Macey MR, Raynor MC
Seminars in interventional radiology 2016; (33(3)):217-23 doi:10.1055/s-0036-1586142.
PMID: 27582609
5
Comparative RNA-sequencing analysis of the prostate in a mouse model of benign prostatic hyperplasia with bladder outlet obstruction.
Tang X, Liu Z, Ren J, et al.
Molecular and cellular biochemistry 2023; (478(12)):2721-2737 doi:10.1007/s11010-023-04695-2.
PMID: 36920576
6
[Diagnostic procedures and diagnostic strategy for lower urinary tract symptoms/benign prostatic hyperplasia : An overview].
Bschleipfer T, Oelke M, Rieken M
Der Urologe. Ausg. A 2019; (58(3)):238-247 doi:10.1007/s00120-019-0870-0.
PMID: 30796463
7
Comparison of the short-term efficacy and safety of bipolar transurethral electro vaporization and holmium laser enucleation of the prostate for moderate and large benign prostatic enlargement.
Hayashi Y, Yoneyama S, Takizawa A, et al.
BMC urology 2023; (23(1)):50 doi:10.1186/s12894-023-01215-8.
PMID: 36991392
8
Holmium laser enucleation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
Sathianathen N, Hwang EC, Brown SJ, et al.
The Cochrane database of systematic reviews 2026; (9()):CD013291 doi:10.1002/14651858.CD013291.pub2.
PMID: 42713842
9
Holmium laser enucleation of the prostate (HoLEP): a review and update.
Das AK, Teplitsky S, Humphreys MR
The Canadian journal of urology 2019; (26(4 Suppl 1)):13-19.
PMID: 31481144
10
Reoperation for Benign Prostatic Obstruction Following Transurethral Resection and Holmium Laser Enucleation of the Prostate: A 3-year Follow-up Study of Over 33 000 Primary Surgical Interventions.
Gilfrich C, May M, Gratzke C, et al.
European urology focus 2025; (11(4)):609-617 doi:10.1016/j.euf.2025.02.017.
PMID: 40234113
11
Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline Amendment 2020.
Parsons JK, Dahm P, Köhler TS, et al.
The Journal of urology 2020; (204(4)):799-804 doi:10.1097/JU.0000000000001298.
PMID: 32698710
12
Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study.
Roehrborn CG, Barkin J, Gange SN, et al.
The Canadian journal of urology 2017; (24(3)):8802-8813.
PMID: 28646935
13
Convective Water Vapor Energy Ablation (Rezum®) Versus Prostatic Urethral Lift (Urolift®): A 2-Year Prospective Study.
Law YXT, Chen WJK, Shen L, et al.
Journal of endourology 2024; (38(12)):1387-1394 doi:10.1089/end.2024.0400.
PMID: 39302046
14
Prospective Trial of Water Vapor Thermal Therapy for Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia in Subjects with a Large Prostate: 6- and 12-month Outcomes.
Woo H, Levin R, Cantrill C, et al.
European urology open science 2023; (58()):64-72 doi:10.1016/j.euros.2023.10.006.
PMID: 38152482
15
Real-world comparison of Rezūm® water vapor therapy and transurethral resection of the prostate using a pragmatic composite definition of procedural success.
Pina-Vaz T, Costa Silva A, Henriques M, et al.
World journal of urology 2026; (44(1)).
PMID: 41739198
16
Comparison of holmium laser enucleation and transurethral resection of prostate in benign prostatic hyperplasia: a systematic review and meta-analysis.
Chen F, Chen Y, Zou Y, et al.
The Journal of international medical research 2023; (51(8)):3000605231190763 doi:10.1177/03000605231190763.
PMID: 37561537
17
Prospective, randomized, multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12-month results from the BPH6 study.
Sønksen J, Barber NJ, Speakman MJ, et al.
European urology 2015; (68(4)):643-52.
PMID: 25937539
18
Holmium Laser Enucleation of the Prostate: Patient Selection and Outcomes.
Kuebker JM, Miller NL
Current urology reports 2017; (18(12)):96 doi:10.1007/s11934-017-0746-z.
PMID: 29046983
19
Effectiveness of convective water vapor energy therapy versus prostatic urethral lift for symptomatic benign prostatic hyperplasia: a systematic review and indirect comparison.
Tallman CT, Zantek PF, Hernandez N, et al.
World journal of urology 2021; (39(9)):3207-3215 doi:10.1007/s00345-021-03595-8.
PMID: 33515055
20
Impact of Endoscopic Bladder Outlet Procedures on Medical and Surgical Retreatment: A Large Population Analysis.
Helman T, Patil D, Marthi S, Browne B
Journal of endourology 2025; (39(6)):608-616 doi:10.1089/end.2024.0741.
PMID: 40227061
21
The incidence of urethral stricture and bladder neck contracture with transurethral resection vs. holmium laser enucleation of prostate: A matched, dual-center study.
Elsaqa M, Serag M, Leenlani N, et al.
Canadian Urological Association journal = Journal de l'Association des urologues du Canada 2023; (17(1)):E35-E38 doi:10.5489/cuaj.7967.
PMID: 36121881

This page is for informational purposes only and does not constitute medical advice. A urologist can assess your prostate, urinary health, and personal priorities to recommend an appropriate treatment.

Get notified when new evidence is published on prostatic adenoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Guide Contents